X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (43588) 43588
Newspaper Article (135) 135
Government Document (64) 64
Newsletter (51) 51
Book Chapter (19) 19
Magazine Article (18) 18
Book / eBook (17) 17
Dissertation (9) 9
Conference Proceeding (8) 8
Web Resource (5) 5
Publication (3) 3
Streaming Video (3) 3
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (39724) 39724
female (28907) 28907
oncology (20424) 20424
breast cancer (18977) 18977
cancer (16919) 16919
middle aged (12535) 12535
animals (12254) 12254
breast-cancer (10718) 10718
breast neoplasms - pathology (10300) 10300
adult (9861) 9861
aged (9394) 9394
tumors (9366) 9366
cell line, tumor (8685) 8685
male (8287) 8287
mice (8131) 8131
medicine (7904) 7904
research article (7902) 7902
metastasis (7805) 7805
multidisciplinary sciences (7640) 7640
expression (7347) 7347
breast neoplasms - immunology (7159) 7159
science (6960) 6960
research (6541) 6541
prognosis (6336) 6336
gene expression (6294) 6294
analysis (5518) 5518
breast neoplasms - metabolism (5511) 5511
proteins (5418) 5418
breast neoplasms - genetics (5333) 5333
immunology (5207) 5207
cell biology (5045) 5045
chemotherapy (5010) 5010
immunohistochemistry (4964) 4964
apoptosis (4798) 4798
health aspects (4556) 4556
pathology (4482) 4482
genetic aspects (4413) 4413
care and treatment (4204) 4204
breast neoplasms - drug therapy (4131) 4131
carcinoma (4022) 4022
gene expression regulation, neoplastic (3833) 3833
survival (3807) 3807
cancer therapies (3794) 3794
metastases (3621) 3621
biology (3609) 3609
aged, 80 and over (3484) 3484
signal transduction (3472) 3472
risk factors (3401) 3401
patients (3390) 3390
medical prognosis (3369) 3369
development and progression (3353) 3353
cancers and neoplasms (3351) 3351
genes (3257) 3257
medical research (3256) 3256
kinases (3231) 3231
cells (3213) 3213
cell proliferation (3136) 3136
studies (3110) 3110
immunotherapy (2986) 2986
mutation (2919) 2919
surgery (2908) 2908
biomarkers (2751) 2751
biochemistry & molecular biology (2698) 2698
medicine and health sciences (2620) 2620
neoplasm staging (2590) 2590
therapy (2576) 2576
cancer research (2561) 2561
genetics (2538) 2538
medicine, research & experimental (2528) 2528
growth (2524) 2524
tumor cells, cultured (2507) 2507
neoplasm metastasis (2491) 2491
neoplasms - immunology (2451) 2451
breast neoplasms - therapy (2449) 2449
diagnosis (2434) 2434
biology and life sciences (2329) 2329
breast (2323) 2323
cell cycle (2314) 2314
medicine & public health (2282) 2282
activation (2271) 2271
biochemistry (2271) 2271
oncology, experimental (2221) 2221
risk (2214) 2214
angiogenesis (2133) 2133
lung cancer (2100) 2100
deoxyribonucleic acid--dna (2063) 2063
mice, inbred balb c (2058) 2058
treatment outcome (2028) 2028
physiological aspects (2006) 2006
stem cells (2000) 2000
breast neoplasms - diagnosis (1976) 1976
mice, nude (1909) 1909
cell growth (1899) 1899
antineoplastic agents - pharmacology (1896) 1896
neoplasms - pathology (1889) 1889
inhibition (1880) 1880
dna (1879) 1879
colorectal cancer (1870) 1870
antineoplastic agents - therapeutic use (1855) 1855
biomedicine (1841) 1841
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (12) 12
Online Resources - Online (4) 4
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Humber River Regional Hospital - Church Stacks (2) 2
Humber River Regional Hospital - Finch Stacks (2) 2
Lakeridge Health Sciences - Oshawa (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (42944) 42944
Japanese (222) 222
Russian (219) 219
German (218) 218
French (165) 165
Chinese (157) 157
Italian (67) 67
Spanish (57) 57
Polish (36) 36
Serbian (13) 13
Czech (11) 11
Hungarian (10) 10
Dutch (8) 8
Danish (7) 7
Portuguese (7) 7
Hebrew (5) 5
Korean (5) 5
Norwegian (5) 5
Swedish (5) 5
Croatian (4) 4
Slovak (3) 3
Finnish (2) 2
Romanian (2) 2
Arabic (1) 1
Bulgarian (1) 1
Icelandic (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British journal of cancer, ISSN 1532-1827, 2015, Volume 112, Issue 6, pp. 1067 - 1075
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 4, pp. 676 - 681
Abstract We wanted to determine whether allogeneic hematopoietic stem cell transplantation (HSCT) may result in long-term survival in patients with solid... 
Hematology, Oncology and Palliative Medicine | Pancreatic adenocarcinoma | Allogeneic hematopoietic stem cell transplantation | Colon carcinoma | Renal carcinoma | Cholangiocarcinoma | DONOR | BONE-MARROW | GRAFT | IMMUNOLOGY | VERSUS-HOST-DISEASE | TRANSPLANTATION | BREAST-CANCER | PRIMARY LIVER-CANCER | LEUKEMIA | HEMATOLOGY | COLON-CARCINOMA | MARROW TRANSPLANTATION | BLOOD | Adenocarcinoma - pathology | Follow-Up Studies | Breast Neoplasms - immunology | Humans | Middle Aged | Kidney Neoplasms - immunology | Male | Graft vs Host Disease - immunology | Cyclophosphamide - therapeutic use | Transplantation, Homologous | Prostatic Neoplasms - immunology | Prostatic Neoplasms - therapy | Breast Neoplasms - therapy | Bile Duct Neoplasms - immunology | Neoplasm Metastasis | Graft vs Host Disease - mortality | Colonic Neoplasms - immunology | Adult | Female | Pancreatic Neoplasms - mortality | Transplantation Conditioning - methods | Graft vs Host Disease - diagnosis | Kidney Neoplasms - therapy | Colonic Neoplasms - therapy | Prostatic Neoplasms - pathology | Colonic Neoplasms - mortality | Adenocarcinoma - immunology | Pancreatic Neoplasms - pathology | Hematopoietic Stem Cell Transplantation | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Kidney Neoplasms - mortality | Myeloablative Agonists | Prostatic Neoplasms - mortality | Graft vs Host Disease - pathology | Bile Duct Neoplasms - therapy | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Bile Duct Neoplasms - mortality | Colonic Neoplasms - pathology | Pancreatic Neoplasms - immunology | Survival Analysis | Breast Neoplasms - mortality | Kidney Neoplasms - pathology | Aged | Bile Duct Neoplasms - pathology | Adenocarcinoma - mortality | Pancreatic Neoplasms - therapy | Liver cancer | Colon cancer | Pancreatic cancer | Liver | Mortality | Stem cells | Transplantation | Metastasis | Health aspects | Prostate cancer | Risk factors | Hematopoietic stem cells | College teachers
Journal Article
Cancer Research, ISSN 0008-5472, 04/2011, Volume 71, Issue 7, pp. 2600 - 2610
Journal Article
Cancer Discovery, ISSN 2159-8274, 06/2011, Volume 1, Issue 1, pp. 54 - 67
Immune-regulated pathways influence multiple aspects of cancer development. In this article we demonstrate that both macrophage abundance and T-cell abundance... 
MAMMARY-TUMORS | COLONY-STIMULATING FACTOR | ONCOLOGY | ANGIOGENIC SWITCH | MOUSE MODEL | RECEPTOR EXPRESSION | TUMOR-ASSOCIATED MACROPHAGES | SUPPRESSOR-CELLS | FACTOR-I | T-CELLS | ENDOTHELIAL GROWTH-FACTOR | Mammary Neoplasms, Experimental - immunology | Lung Neoplasms - drug therapy | Receptor, Macrophage Colony-Stimulating Factor - immunology | Epithelial Cells - metabolism | Paclitaxel - pharmacology | Prognosis | Follow-Up Studies | Breast Neoplasms - immunology | Epithelial Cells - drug effects | Humans | Lung Neoplasms - metabolism | Mammary Neoplasms, Experimental - metabolism | Receptor, Macrophage Colony-Stimulating Factor - metabolism | Breast Neoplasms - metabolism | Leukocytes - immunology | Signal Transduction - immunology | Neoplasm Metastasis | Lung Neoplasms - secondary | CD8-Positive T-Lymphocytes - metabolism | Female | Macrophages - immunology | Mammary Neoplasms, Experimental - drug therapy | Survival Rate | Macrophage Colony-Stimulating Factor - metabolism | Breast Neoplasms - drug therapy | Macrophage Colony-Stimulating Factor - immunology | Tumor Microenvironment - immunology | Disease-Free Survival | Lung Neoplasms - immunology | Macrophages - metabolism | Animals | Signal Transduction - drug effects | CD8-Positive T-Lymphocytes - drug effects | Epithelial Cells - immunology | Leukocytes - drug effects | Macrophages - drug effects | Aged | Mice | CD8-Positive T-Lymphocytes - immunology | Leukocytes - metabolism | Cohort Studies
Journal Article
Breast cancer research : BCR, ISSN 1465-542X, 2015, Volume 17, Issue 1, p. 45
Journal Article
Advances in Chronic Kidney Disease, ISSN 1548-5595, 2014, Volume 21, Issue 1, pp. 106 - 113
Kidney transplant recipients are at increased risk for development of malignancy compared with the general population, and malignancies occur at an earlier... 
Nephrology | Immunosuppression | Malignancy | Kidney transplant | Cancer screening | AZATHIOPRINE | RISK | HUMAN-PAPILLOMAVIRUS | RECIPIENTS | MAMMOGRAPHY | CIGARETTE-SMOKING | NONMELANOMA SKIN-CANCER | UROLOGY & NEPHROLOGY | INFECTION | IMMUNOSUPPRESSIVE DRUGS | EPSTEIN-BARR-VIRUS | Kidney Neoplasms - epidemiology | Breast Neoplasms - immunology | Humans | Uterine Cervical Neoplasms - epidemiology | Kidney Neoplasms - immunology | Lymphoproliferative Disorders - immunology | Neoplasms - diagnosis | Kidney Transplantation - statistics & numerical data | Carcinoma, Renal Cell - immunology | Colorectal Neoplasms - diagnosis | Kidney Neoplasms - diagnosis | Skin Neoplasms - diagnosis | Female | Anus Neoplasms - epidemiology | Breast Neoplasms - epidemiology | Colorectal Neoplasms - epidemiology | Kidney Failure, Chronic - surgery | Uterine Cervical Neoplasms - diagnosis | Skin Neoplasms - immunology | Early Detection of Cancer | Uterine Cervical Neoplasms - immunology | Skin Neoplasms - epidemiology | Lymphoproliferative Disorders - epidemiology | Anus Neoplasms - diagnosis | Carcinoma, Renal Cell - epidemiology | Anus Neoplasms - immunology | Colorectal Neoplasms - immunology | Lymphoproliferative Disorders - diagnosis | Neoplasms - immunology | Carcinoma, Renal Cell - diagnosis | Immunosuppressive Agents - adverse effects | Breast Neoplasms - diagnosis | Immunocompromised Host | Neoplasms - epidemiology
Journal Article
The Journal of clinical investigation, ISSN 1558-8238, 2017, Volume 128, Issue 1, pp. 248 - 266
During tumor progression, immune system phagocytes continually clear apoptotic cancer cells in a process known as efferocytosis. However, the impact of... 
BREAST-CANCER | MEDICINE, RESEARCH & EXPERIMENTAL | CELLS | IN-VIVO | STAT3 | MONOCYTES | EFFEROCYTOSIS | MARROW MACROPHAGES | CANCER PROGRESSION | NF-KAPPA-B | EXPRESSION | Inflammation - pathology | Neoplasm Proteins - immunology | Bone Neoplasms - secondary | Apoptosis - genetics | Male | Phagocytosis - genetics | Bone Neoplasms - pathology | Prostatic Neoplasms - immunology | Neoplasms, Experimental - pathology | Neoplasm Metastasis | Prostatic Neoplasms - genetics | Myeloid Cells - immunology | Neoplasms, Experimental - immunology | Neoplasms, Experimental - genetics | Bone Neoplasms - genetics | Neoplasm Proteins - genetics | Prostatic Neoplasms - pathology | Phagocytosis - immunology | Bone Neoplasms - immunology | Inflammation - immunology | Chemokine CXCL5 - genetics | Animals | Apoptosis - immunology | Chemokine CXCL5 - immunology | Cell Line, Tumor | Inflammation - genetics | Mice | Myeloid Cells - pathology | Cytokines | Growth | Analysis | Development and progression | Inflammation | Metastasis | Macrophages | Prostate cancer | Apoptosis | Animal models | Immune clearance | Bone tumors | Metastases | Phagocytes | Bone growth | Peripheral blood | Bone marrow | Immune system | NF-κB protein | Vertebrae | Stat3 protein | Breast cancer | Gene expression | Serum levels | Studies | Monocytes | Bone cancer | Prostate | Tumors
Journal Article
The Journal of biological chemistry, ISSN 1083-351X, 2014, Volume 289, Issue 48, pp. 33481 - 33491
Lectin galactoside-binding soluble 3 binding protein (LGALS3BP, also called Mac-2 binding protein) is a heavily glycosylated secreted molecule that has been... 
BREAST-CANCER | CYCLOPHILIN-C | NK CELLS | MAC-2-BINDING PROTEIN | LUNG-CARCINOMA | BIOCHEMISTRY & MOLECULAR BIOLOGY | INNATE IMMUNE-RESPONSE | GROUP-B STREPTOCOCCUS | C-ASSOCIATED PROTEIN | SIALIC-ACID DIVERSITY | ANTIGEN 90K | Prostatic Neoplasms - metabolism | Tumor Escape | Colorectal Neoplasms - genetics | Humans | Sialic Acid Binding Ig-like Lectin 3 - immunology | Antigens, Neoplasm - biosynthesis | Neoplasm Proteins - immunology | Male | Neoplasm Proteins - metabolism | Prostatic Neoplasms - immunology | Prostatic Neoplasms - genetics | HEK293 Cells | Female | Neoplasm Proteins - genetics | Carrier Proteins - immunology | Colorectal Neoplasms - metabolism | Sialic Acid Binding Ig-like Lectin 3 - metabolism | Glycoproteins - genetics | Sialic Acid Binding Ig-like Lectin 3 - genetics | Antigens, Neoplasm - genetics | Prostatic Neoplasms - pathology | Antigens, Neoplasm - immunology | Carrier Proteins - biosynthesis | Immunologic Factors - immunology | Gene Expression Regulation, Neoplastic - immunology | Immunologic Factors - genetics | Glycoproteins - biosynthesis | Carrier Proteins - genetics | Glycoproteins - immunology | Animals | Colorectal Neoplasms - immunology | Up-Regulation - immunology | Biomarkers, Tumor - genetics | Mice | Colorectal Neoplasms - pathology | Biomarkers, Tumor - immunology | Biomarkers, Tumor - biosynthesis | Immunologic Factors - biosynthesis | Galectin | Sialic Acid | LGALS3BP | Glycobiology | Tumor Immunology | Glycobiology and Extracellular Matrices | Siglecs | Cancer
Journal Article
Cancer science, ISSN 1347-9032, 2016, Volume 107, Issue 7, pp. 1039 - 1046
Antibody–drug conjugates deliver anticancer agents selectively and efficiently to tumor tissue and have significant antitumor efficacy with a wide therapeutic... 
topoisomerase I inhibitor | T‐DM | HER2 | bystander killing | Antibody‐drug conjugate | T-DM | Antibody-drug conjugate | HODGKINS LYMPHOMA | GEMTUZUMAB OZOGAMICIN | ADVANCED BREAST-CANCER | BRENTUXIMAB VEDOTIN | ACUTE MYELOID-LEUKEMIA | TRASTUZUMAB EMTANSINE | CHALLENGES | THERAPY | ONCOLOGY | EXPRESSION | CATHEPSIN-B | Receptor, ErbB-2 - genetics | Breast Neoplasms - immunology | Humans | Ado-Trastuzumab Emtansine | Stomach Neoplasms - pathology | Maytansine - pharmacology | Immunoconjugates - immunology | Breast Neoplasms - enzymology | Immunoconjugates - pharmacology | Topoisomerase I Inhibitors - pharmacology | Neoplasms - genetics | Antibodies, Monoclonal, Humanized - pharmacology | Female | Camptothecin - immunology | Receptor, ErbB-2 - immunology | Camptothecin - analogs & derivatives | Stomach Neoplasms - enzymology | Stomach Neoplasms - genetics | Maytansine - analogs & derivatives | Neoplasms - enzymology | Stomach Neoplasms - immunology | Animals | Breast Neoplasms - genetics | Bystander Effect - drug effects | Breast Neoplasms - pathology | Mice, Nude | Neoplasms - immunology | Cell Membrane Permeability - drug effects | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | Antibodies, Monoclonal, Humanized - immunology | Neoplasms - pathology | Camptothecin - pharmacology | Maytansine - immunology | Trastuzumab | Viral antibodies | Epidermal growth factor | Imaging systems | Antibodies | Permeability | Drug therapy | Biopharmaceutics | Tumors | Antigens | Hematology | Laboratories | Toxicity | DNA topoisomerase | Polymerization | Clinical trials | Cytotoxicity | Breast cancer | ErbB-2 protein | Stomach cancer | Hypotheses | Antitumor agents | Xenografts | Antitumor activity | Lymphomas | Drug dosages | Payloads | Index Medicus | Original
Journal Article
Clinical Immunology, ISSN 1521-6616, 2016, Volume 166-167, pp. 48 - 58
Abstract We designed a phase I trial to investigate the safety, immune responses and clinical benefits of a five-peptide cancer vaccine in combination with... 
Allergy and Immunology | Translational research | Five-peptide cancer vaccine | Cyclophosphamide | Regulatory T cells | INTERLEUKIN-2 | IMMUNE-RESPONSE | LUNG | TESTIS ANTIGENS | IMMUNOLOGY | EPITOPE-PEPTIDES | IDENTIFICATION | BREAST-CANCER | IMMUNOTHERAPY | COLORECTAL-CANCER | REGULATORY T-CELLS | Lung Neoplasms - drug therapy | Cyclophosphamide - administration & dosage | Colorectal Neoplasms - genetics | Humans | Middle Aged | HLA-A24 Antigen - genetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epitopes - administration & dosage | Male | Cyclophosphamide - adverse effects | Peptides - administration & dosage | Dose-Response Relationship, Drug | Epitopes - immunology | Neoplasms - genetics | T-Lymphocytes - metabolism | T-Lymphocytes - drug effects | Colorectal Neoplasms - drug therapy | Leukopenia - chemically induced | Aged, 80 and over | Adult | Female | Vaccines, Subunit - adverse effects | Lung Neoplasms - genetics | Stomach Neoplasms - genetics | HLA-A24 Antigen - immunology | Drug Administration Schedule | Cancer Vaccines - administration & dosage | Peptides - immunology | Kaplan-Meier Estimate | Cancer Vaccines - adverse effects | Treatment Outcome | Cyclophosphamide - immunology | Vaccines, Subunit - immunology | Stomach Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - immunology | Neoplasms - drug therapy | Stomach Neoplasms - immunology | Cancer Vaccines - immunology | Lung Neoplasms - immunology | Colorectal Neoplasms - immunology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms - immunology | Vaccines, Subunit - administration & dosage | T-Lymphocytes - immunology | Aged | Cancer vaccines | Antigens | Chemotherapy | Peptides | Vaccination | Colorectal cancer | Clinical trials | Product development | T cells | Cancer | Tumors
Journal Article
Cancer research (Chicago, Ill.), ISSN 1538-7445, 2012, Volume 72, Issue 16, pp. 3948 - 3957
Journal Article